[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.119.60. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
May 1978

Cicatricial Pemphigoid (Brunsting-Perry Type)Case Report and Immunofluorescence Findings

Author Affiliations

From the Department of Dermatology, Henry Ford Hospital, Detroit. Dr Jacoby is now with the Department of Internal Medicine, Division of Dermatology, Arizona Medical Center, and in private practice, Tucson; Dr Bartholome in private practice in Muncie, Ind; Dr Ramchand in Niagara Falls, NY; and Dr Simmons in Detroit.

Arch Dermatol. 1978;114(5):779-781. doi:10.1001/archderm.1978.01640170079018
Abstract

• We describe clinical and immunofluorescence findings of a patient with Brunsting-Perry-type cicatricial pemphigoid. Direct immunofluorescence showed tissue-fixed basement membrane zone antibodies similar to those characteristic of bullous pemphigoid. Circulating antibodies to the basement membrane zone were not found. Brunsting-Perry-type cicatricial pemphigoid probably represents a clinical variation midway in the cicatricial pemphigoid-bullous pemphigoid spectrum of disease. Management with intralesional corticosteroids was successful in controlling the skin lesions.

(Arch Dermatol 114:779-781, 1978)

×